Volume 114

Glucagon and hyperglycaemia in diabetes

P. E. Cryer (see accompanying paper pp. 591–601).........589–590

Published as Immediate Publication 15 January 2008, doi:10.1042/CS20070434

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper

Is adipose tissue lipolysis always an adaptive response to starvation?: implications for non-alcoholic fatty liver disease

S. K. Gan and G. F. Watts (see accompanying paper, pp. 547–552).........543–545

Published as Immediate Publication 8 January 2008, doi:10.1042/CS20070461

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper

Erythropoietin in cardiovascular diseases: exploring new avenues

P. van der Meer, D. J. van Veldhuisen and J. L. Januzzi (see accompanying paper pp. 293–304).........289–291

Published as Immediate Publication 14 November 2007, doi:10.1042/CS20070392

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper

Does compensatory nitric oxide and angiotensin II receptor activity reduce arterial stiffness in early-stage insulin resistance?

R. J. Woodman (see accompanying paper pp. 139–147).........119–121

Published as Immediate Publication 19 September 2007, doi:10.1042/CS20070321

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper

Volume 113

High-fat diets: healthy or unhealthy?

M. C. Guldstrand and C. L. Simberg (see accompanying paper pp. 417–425).........397–399

Published as Immediate Publication 23 August 2007, doi:10.1042/CS20070263

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper

Familial combined hyperlipidaemia: how can genetic disorders be common, complex and comprehensible?

A. Sniderman, S. D. Bailey and J. C. Engert (see accompanying paper pp. 375–381).........365–367

Published as Immediate Publication 4 July 2007, doi:10.1042/CS20070220

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF | Accompanying paper

Normative values, reliability and sample size estimates in heart rate variability

G. Sandercock (see accompanying paper pp. 131–140).........129–130

Published as Immediate Publication 23 April 2007, doi:10.1042/CS20070137

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF

C-reactive protein: a marker or a player?

T. Nyström (see accompanying paper pp. 103–108).........79–81

Published as Immediate Publication 23 April 2007, doi:10.1042/CS20070121

Abstract | Enhanced Full Text | Legacy HTML | Full text PDF

Volume 111

Testosterone and vascular reactivity

R. Iliescu and J. F. Reckelhoff .........251–252

b-Adrenergic receptor blockers and the treatment of vasovagal syncope: more nails in the coffin!

C. J. Mathias .........189–191

Are the lipid-modifying effects of fibrates mediated by alterations in plasma lipid transfer activity?

G. F. Lewis .........185–187

Volume 110

Local inflammation, endothelial dysfunction and fibrinolysis in coronary heart disease

G. D. O. Lowe .........327–328

How does endothelin induce vascular oxidative stress in mineralocorticoid hypertension?

D. M. Pollock .........205–206

What role do adrenoreceptor polymorphisms play in modifying cardiovascular responses in obstructive sleep apnoea?

N. McArdle .........89–91

Volume 109

Coronary flow responses to exercise training: further evidence of the benefit of an underutilized therapeutic modality

T. H. Marwick .........265–266

Can we diagnose, treat or even understand neurally mediated syncope?

S. R. Raj, A. Diedrich and I. Biaggioni.........161–163

Volume 108

C-reactive protein and statins: IL-8 as a molecular link?

P. E. Szmitko and S. Verma .........493–495

New evidence of baroreflex dysfunction in congenital central hypoventilation syndrome

P. van de Borne .........215–216

Volume 107

Running for health: how much running for how much health?

K. McCully .........559–560

Resolving inconsistency in the results of genetic association studies of cardiovascular disease

A. Hingorani .........251–253

Renin–angiotensin vaccine: old story, new project ‘efficacy versus safety’

J.-B. Michel .........145–147

Stroke and blood pressure variability

J. C. T. Pepperell .........27–28

Volume 106

Sympathetic overactivity in ischaemic heart disease

A. Malliani and N. Montano .........567–568

Inspiratory flow limitation in obstructive sleep apnoea patients

R. Farré .........563–565

Diet, the endothelium and atherosclerosis

A. D. Hingorani .........447–448

Inflammation and endothelial dysfunction: intimate companions in the pathogenesis of vascular disease?

N. Sattar .........443–445

Can mild-to-moderate hyperhomocysteinaemia impair endothelial function in the absence of other risk factors for cardiovascular disease?

M. L. H. Honing and C. D. A. Stehouwer ..........345–346

Aging, physical fitness and endothelial function: are all ultracentenarians marathon runners?

G. Grassi.........239–240

Antioxidant defence mechanisms: new players in the pathogenesis of non-alcoholic steatohepatitis?

I. A. Leclercq.........235–237

Protein, programming and plumpness: is there a link?

R. R. Huxley.........113–114

A feeling in the waters: diagnosis of heart failure using urinary natriuretic peptides

H. Krum and D. Liew.........111–112

Genetic risk markers for post-angioplasty restenosis: what should we expect?

F. R. Green.........1–2